Given its high levels of expression within an MS-affected CNS and its ability to trigger IFN-γ release by the natural repertoire of HspB5-reactive human memory T cells, HspB5 is likely to be an important driver of pathogenic T-cell responses within the CNS during MS. Here, IFNG is linked to myeloid sarcoma.